Chemical Structure (Acy06 0002 01)
Avaclyr Ointment
Product Images NDC 48102-028
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Avaclyr (NDC 48102-028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fera Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (30 mg Carton Label)
This text appears to be a prescription information for an eye ointment called Avaclyre. It recommends applying a 1 cm ribbon of the ointment in the lower cul-de-sac of the affected eye 5 times a day until healed, then reducing to 3 times a day for 7 days. Each gram of Avaclyre contains acyclovir USP 30 mg in an ointment base of white petrolatum. The ointment should be stored at a temperature between 15°C to 25°C. The product is manufactured in Canada by Fera Pharmaceuticals.*
Principal Display Panel (30 mg Tube Label)
This is a description for an ophthalmic ointment called Avaclyre® with the active ingredient acyclovir, presented in a 3% concentration. Each gram of this ointment contains 30 mg of acyclovir USP in a base of white petrolatum. The product is intended for topical ophthalmic use and is labeled as sterile. It comes in a 3.5g package and should be stored at a temperature range of 15°C to 25°C (59°F-77°F). Manufacturing is done in Canada for Fera Pharmaceuticals, LLC based in Locust Valley, NY. For detailed dosage instructions, refer to the prescribing information provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
